Need help choosing the right code?
Ask CasePilot about procedures, modifiers, bundling, and coding guidance.
Try CasePilot© Copyright 2026 American Medical Association. All rights reserved.
| Short Descr | NEURO ALZ DS βAMYL&TAU PRTN | Medium Descr | NEURO ALZ DS BETA AMYL&TAU PRTN BLD LC-MS/MS ALG | Long Descr | Neurology (Alzheimer disease), beta amyloid (Aβ40, Aβ42, Aβ42/40 ratio) and tau-protein (ptau217, np-tau217, ptau217/np-tau217 ratio), blood, immunoprecipitation with quantitation by liquid chromatography with tandem mass spectrometry (LC-MS/MS), algorithm score reported as likelihood of positive or negative for amyloid plaques | CLIA Waived (QW) | No | APC Status Indicator | Conditionally packaged laboratory tests | Berenson-Eggers TOS (BETOS) | none | MUE | Not applicable/unspecified. |
|
Date
|
Action
|
Notes
|
|---|---|---|
| 2025-01-01 | Added | First appearance in codebook. |
| 2024-10-01 | Added | Code added |
Get instant expert-level medical coding assistance.